Packages of care for dementia in low- and middle-income countries

PLoS Medicine

Volumn 6, Issue 11, 2009, Pages

  Prince, Martin J ^a   Acosta, Daisy ^b   Castro Costa, Erico ^a,c   Jackson, Jim ^d   Shaji, K S ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Universidad Nacional Pedro Henriquez Urena   (Dominican Republic)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Alzheimer Scotland   (United Kingdom)

^e Government Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; DONEPEZIL; GALANTAMINE; HALOPERIDOL; MEMANTINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; SERTRALINE; TRAZODONE;

ALZHEIMER DISEASE; BEHAVIOR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEMENTIA; DIAGNOSTIC TEST; DISEASE COURSE; DRUG EFFICACY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; LOWEST INCOME GROUP; MENTAL DISEASE; PREVALENCE; PSYCHOEDUCATION; PSYCHOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; AGED; DEVELOPING COUNTRY; ELDERLY CARE; METHODOLOGY;

AGED; DELIVERY OF HEALTH CARE; DEMENTIA; DEVELOPING COUNTRIES; HEALTH SERVICES FOR THE AGED; HUMANS;

EID: 72949114286     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000176     Document Type: Review

References (107)

1. World Health Organization (1992) International classification of diseases (10th Revision). Geneva: World Health Organization.
2. Ferri CP, Ames D, Prince M (2004) Behavioral and psychological symptoms of dementia in developing countries. Int Psychogeriatr 16: 441-459.
3. de Vugt ME, Stevens F, Aalten P, Lousberg R, Jaspers N, et al. (2005) A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia. Int Psychogeriatr 17: 577-589.
4. Neuropathology Group Medical Research Council Cognitive Function and Aging Study (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) [comment]. Lancet 357: 169-175.
5. Ritchie K, Kildea D, Robine JM (1992) The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data. Int J Epidemiol 21: 763-769.
6. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, et al. (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366: 2112-2117.
7. Llibre Rodriguez JJ, Ferri CP, Acosta D, Guerra M, Huang Y, et al. (2008) Prevalence of dementia in Latin America, India, and China: a populationbased cross-sectional survey. Lancet 372: 464-474.
8. (1996) The Global Burden of Disease. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge (Massachusetts): Harvard School of Public Health, Harvard University Press.
9. Wimo A, Winblad B, Jonsson L (2007) An estimate of the total worldwide societal costs of dementia in 2005. Alzheimer's and Dementia 81-91.
10. 10/66 Dementia Research Group (2004) Care arrangements for people with dementia in developing countries. Int J Geriatr Psychiatry 19: 170-177.
11. Prince MJ (2009) The 10/66 dementia research group - 10 years on. Indian Journal of Psychiatry 51: S8-S15.
12. Cohen L (1995) Toward an anthropology of senility: anger, weakness, and Alzheimer's in Banaras, India. Med Anthropol Q 9: 314-334.
13. Patel V, Prince M (2001) Ageing and mental health in a developing country: who cares? Qualitative studies from Goa, India. Psychol Med 31: 29-38.
14. Shaji KS, Smitha K, Praveen Lal K, Prince M (2002) Caregivers Of patients with Alzheimer's disease: a qualitative study from the Indian 10/66 Dementia Research Network. Int J Geriatr Psych 18: 1-6.
15. Prince M, Livingston G, Katona C (2007) Mental health care for the elderly in low-income countries: a health systems approach. World Psychiatry 6: 5-13.
16. Shaji KS, Arun Kishore NR, Lal KP, Prince M (2002) Revealing a hidden problem. An evaluation of a community dementia case-finding program from the Indian 10/66 dementia research network. Int J Geriatr Psych 17: 222-225.
17. Ramos-Cerqueira AT, Torres AR, Crepaldi AL, Oliveira NI, Scazufca M, et al. (2005) Identification of dementia cases in the community: a Brazilian experience. J Am Geriatr Soc 53: 1738-1742.
18. National Collaborating Centre for Mental Health (2007) Dementia. A NICESCIE Guideline on supporting people with dementia and their carers in health and social care. National Clinical Practice Guideline number 42. London: National Institute For Health And Clinical Excellence.
19. Folstein MF, Folstein SE, McHugh PR (1975) 'Mini-mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
20. Ganguli M, Ratcliff G, Chandra V, Sharma S, Gilby J, et al. (1995) A Hindi version of the MMSE: the development of a cognitive screening instrument for a largely illiterate rural elderly population in India. Int J Geriatr Psych 10: 367-377.
21. Xu G, Meyer JS, Huang Y, Du F, Chowdhury M, et al. (2003) Adapting minimental state examination for dementia screening among illiterate or minimally educated elderly Chinese. Int J Geriatr Psychiatry 18: 609-616.
22. Castro-Costa E, Fuzikawa C, Uchoa E, Firmo JO, Lima-Costa MF (2008) Norms for the mini-mental state examination: adjustment of the cut-off point in population-based studies (evidences from the Bambui health aging study). Arq Neuropsiquiatr 66: 524-528.
23. Ng TP, Niti M, Chiam PC, Kua EH (2007) Ethnic and educational differences in cognitive test performance on mini-mental state examination in Asians. Am J Geriatr Psychiatry 15: 130-139.
24. Black SA, Espino DV, Mahurin R, Lichtenstein MJ, Hazuda HP, et al. (1999) The influence of noncognitive factors on the Mini-Mental State Examination in older Mexican-Americans: findings from the Hispanic EPESE. Established Population for the Epidemiologic Study of the Elderly. J Clin Epidemiol 52: 1095-1102.
25. Brodaty H, Low LF, Gibson L, Burns K (2006) What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry 14: 391-400.
26. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M (2003) Dementia diagnosis in developing countries: a cross-cultural validation study. The Lancet 361: 909-917.
27. Liu SI, Prince M, Chiu MJ, Chen TF, Sun YW, et al. (2005) Validity and reliability of a Taiwan Chinese version of the community screening instrument for dementia. Am J Geriatr Psychiatry 13: 581-588.
28. Lecouturier J, Bamford C, Hughes JC, Francis JJ, Foy R, et al. (2008) Appropriate disclosure of a diagnosis of dementia: identifying the key behaviours of 'best practice'. BMC Health Serv Res 8: 95.
29. Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, et al. (2009) Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 5: 245-255.
30. Leonard R, Tinetti ME, Allore HG, Drickamer MA (2006) Potentially modifiable resident characteristics that are associated with physical or verbal aggression among nursing home residents with dementia. Arch Intern Med 166: 1295-1300.
31. Husebo BS, Strand LI, Moe-Nilssen R, Borgehusebo S, Aarsland D, et al. (2008) Who suffers most? Dementia and pain in nursing home patients: a crosssectional study. J Am Med Dir Assoc 9: 427-433.
32. Peters CA, Potter JF, Scholer SG (1988) Hearing impairment as a predictor of cognitive decline in dementia. J Am Geriatr Soc 36: 981-986.
33. Uhlmann RF, Larson EB, Koepsell TD (1986) Hearing impairment and cognitive decline in senile dementia of the Alzheimer's type. J Am Geriatr Soc 34: 207-210.
34. Chapman FM, Dickinson J, McKeith I, Ballard C (1999) Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications. Am J Psychiatry 156: 1983-1985.
35. Ballard C, Bannister C, Graham C, Oyebode F, Wilcock G (1995) Associations of psychotic symptoms in dementia sufferers. Br J Psychiatry 167: 537-540.
36. Eriksson I, Gustafson Y, Fagerstrom L, Olofsson B (2009) Prevalence and factors associated with urinary tract infections (UTIs) in very old women. Arch Gerontol Geriatr. In press.
37. Natalwala A, Potluri R, Uppal H, Heun R (2008) Reasons for hospital admissions in dementia patients in Birmingham, UK, during 2002-2007. Dement Geriatr Cogn Disord 26: 499-505.
38. Rait G, Fletcher A, Smeeth L, Brayne C, Stirling S, et al. (2005) Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community. Age Ageing 34: 242-248.
39. Fuchs-Lacelle S, Hadjistavropoulos T, Lix L (2008) Pain assessment as intervention: a study of older adults with severe dementia. Clin J Pain 24: 697-707.
40. Allen NH, Burns A, Newton V, Hickson F, Ramsden R, et al. (2003) The effects of improving hearing in dementia. Age Ageing 32: 189-193.
41. Gil GP, Ramirez Diaz SP, Ribera Casado JM (2003) Dementia and nutrition. Intervention study in institutionalized patients with Alzheimer disease. J Nutr Health Aging 7: 304-308.
42. Riviere S, Gillette-Guyonnet S, Voisin T, Reynish E, Andrieu S, et al. (2001) A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease. J Nutr Health Aging 5: 295-299.
43. Richard E, Kuiper R, Dijkgraaf MG, van Gool WA (2009) Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial. J Am Geriatr Soc 57: 797-805.
44. Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, et al. (2003) Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J Psychiatry 183: 248-254.
45. Bottino CM, Carvalho IA, Alvarez AM, Avila R, Zukauskas PR, et al. (2005) Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study. Clin Rehabil 19: 861-869.
46. Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A (2003) Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev: CD003260.
47. Woods B, Spector A, Jones C, Orrell M, Davies S (2005) Reminiscence therapy for dementia. Cochrane Database Syst Rev: CD001120.
48. Birks J, Harvey RJ (2006) Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev: CD001190.
49. Birks J, Grimley EJ, Iakovidou V, Tsolaki M, Holt FE (2009) Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev: CD001191.
50. Loy C, Schneider L (2006) Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev: CD001747.
51. Birks J (2006) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev: CD005593.
52. Moraes W, Poyares D, Sukys-Claudino L, Guilleminault C, Tufik S (2008) Donepezil improves obstructive sleep apnea in Alzheimer disease: a doubleblind, placebo-controlled study. Chest 133: 677-683.
53. Caramelli P, Chaves ML, Engelhardt E, Machado JC, Schultz RR, et al. (2004) Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01). Arq Neuropsiquiatr 62: 379-384.
54. Chu LW, Yik PY, Mok W, Chung CP (2007) A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong. Int J Clin Pract 61: 403-410.
55. Burns A, Bernabei R, Bullock R, Cruz Jentoft AJ, Frolich L, et al. (2009) Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. Lancet Neurol 8: 39-47.
56. McShane R, Areosa SA, Minakaran N (2006) Memantine for dementia. Cochrane Database Syst Rev: CD003154.
57. Kavirajan H, Schneider LS (2007) Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol 6: 782-792.
58. Wilcock GK, Ballard CG, Cooper JA, Loft H (2008) Memantine for agitation/ aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. J Clin Psychiatry 69: 341-348.
59. Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, et al. (2007) Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med 357: 1382-1392.
60. Lonergan E, Luxenberg J, Colford J (2002) Haloperidol for agitation in dementia. Cochrane Database Syst Rev: CD002852.
61. Ballard C, Waite J (2006) The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev: CD003476.
62. Schneider LS, Dagerman K, Insel PS (2006) Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebocontrolled trials. Am J Geriatr Psychiatry 14: 191-210.
63. Ballard C, Howard R (2006) Neuroleptic drugs in dementia: benefits and harm. Nat Rev Neurosci 7: 492-500.
64. Schneider LS, Dagerman KS, Insel P (2005) Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294: 1934-1943.
65. Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, et al. (2007) Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 146: 775-786.
66. Kales HC, Valenstein M, Kim HM, McCarthy JF, Ganoczy D, et al. (2007) Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry 164: 1568-1576.
67. Kleijer BC, van Marum RJ, Egberts AC, Jansen PA, Knol W, et al. (2008) Risk of cerebrovascular events in elderly users of antipsychotics. J Psychopharmacol. In press.
68. Douglas IJ, Smeeth L (2008) Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ 337: a1227.
69. Hunkeler EM, Katon W, Tang L, Williams JW, Jr., Kroenke K, et al. (2006) Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ 332: 259-263.
70. Bains J, Birks JS, Dening TR (2002) The efficacy of antidepressants in the treatment of depression in dementia. Cochrane Database Syst Rev: CD003944.
71. Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, et al. (2003) Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry 60: 737-746.
72. Martinon-Torres G, Fioravanti M, Grimley EJ (2004) Trazodone for agitation in dementia. Cochrane Database Syst Rev: CD004990.
73. Pollock BG, Mulsant BH, Rosen J, Sweet RA, Mazumdar S, et al. (2002) Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 159: 460-465.
74. Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, et al. (2004) A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry 19: 9-18.
75. Lonergan ET, Cameron M, Luxenberg J (2004) Valproic acid for agitation in dementia. Cochrane Database Syst Rev: CD003945.
76. Tariot PN, Erb R, Podgorski CA, Cox C, Patel S, et al. (1998) Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 155: 54-61.
77. Olin JT, Fox LS, Pawluczyk S, Taggart NA, Schneider LS (2001) A pilot randomized trial of carbamazepine for behavioral symptoms in treatmentresistant outpatients with Alzheimer disease. Am J Geriatr Psychiatry 9: 400-405.
78. Forbes D, Morgan DG, Bangma J, Peacock S, Pelletier N, et al. (2004) Light therapy for managing sleep, behaviour, and mood disturbances in dementia. Cochrane Database Syst Rev: CD003946.
79. Chung JC, Lai CK, Chung PM, French HP (2002) Snoezelen for dementia. Cochrane Database Syst Rev: CD003152.
80. Ballard CG, O'Brien JT, Reichelt K, Perry EK (2002) Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 63: 553-558.
81. Viggo HN, Jorgensen T, Ortenblad L (2006) Massage and touch for dementia. Cochrane Database Syst Rev: CD004989.
82. Remington R (2002) Calming music and hand massage with agitated elderly. Nurs Res 51: 317-323.
83. Sorensen S, Duberstein P, Gill D, Pinquart M (2006) Dementia care: mental health effects, intervention strategies, and clinical implications. Lancet Neurol 5: 961-973.
84. Pinquart M, Sorensen S (2006) Helping caregivers of persons with dementia: which interventions work and how large are their effects? Int Psychogeriatr 18: 577-595.
85. Smits CH, de LJ, Droes RM, Meiland F, Vernooij-Dassen M, et al. (2007) Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review. Int J Geriatr Psychiatry 22: 1181-1193.
86. Brodaty H, Green A, Koschera A (2003) Meta-analysis of psychosocial interventions for caregivers of people with dementia. J Am Geriatr Soc 51: 657-664.
87. Lee H, Cameron M (2004) Respite care for people with dementia and their carers. Cochrane Database Syst Rev: CD004396.
88. Spijker A, Vernooij-Dassen M, Vasse E, Adang E, Wollersheim H, et al. (2008) Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis. J Am Geriatr Soc 56: 1116-1128.
89. Dias A, Dewey ME, D'Souza J, Dhume R, Motghare DD, et al. (2008) The effectiveness of a home care program for supporting caregivers of persons with dementia in developing countries: a randomised controlled trial from Goa, India. PLoS ONE 3: e2333. doi:10.1371/journal.pone.0002333.
90. Gavrilova SI, Ferri CP, Mikhaylova N, Sokolova O, Banerjee S, et al. (2008) Helping carers to care-The 10/66 dementia research group's randomized control trial of a caregiver intervention in Russia. Int J Geriatr Psychiatry 24: 347-354.
91. Graham N, Brodaty H (1997) Alzheimer's Disease International. Int J Geriatr Psych 12: 691-692.
92. Prince M, Acosta D, Albanese E, Arizaga R, Ferri CP, et al. (2008) Ageing and dementia in low and middle income countries-Using research to engage with public and policy makers. Int Rev Psychiatry 20: 332-343.
93. Epping-Jordan JE, Pruitt SD, Bengoa R, Wagner EH (2004) Improving the quality of health care for chronic conditions. Qual Saf Health Care 13: 299-305.
94. Sousa RM, Scazufca M, Menezes PR, Crepaldi AL, Prince MJ (2009) Feasibility and reliability of the elderly version of the Camberwell Assessment of Needs (CANE): results from the Sao Paulo Ageing & Health Study. Rev Bras Psiquiatr 31: 34-38.
95. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, et al. (2008) Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 7: 812-826.
96. Rafii MS, Aisen PS (2009) Recent developments in Alzheimer's disease therapeutics. BMC Med 7: 7.
97. World Health Organization (2004) Towards age-friendly primary health care. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/ publications/2004/9241592184.pdf. Accessed 5 October 2009.
98. United Nations (2002) In: Report of the Second World Assembly on Ageing; Madrid 8-12 April 2002. A/CONF.197/9. Available: http://www.un.org/esa/socdev/ ageing/secondworld02.html. Accessed 5 October 2009.
99. Shaji KS (2009) Dementia care in developing countries: the road ahead. Indian Journal of Psychiatry 51: S5-S7.
100. Callahan CM, Boustani MA, Unverzagt FW, Austrom MG, Damush TM, et al. (2006) Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA 295: 2148-2157.
101. Patel V, Simon G, Chowdhary N, Kaaya S, Araya R (2009) Packages of care for depression in low and middle income countries. PLoS Med 6: e1000159. doi:10.1371/journal.pmed.journal.pmed.1000159.
102. Hall KS, Hendrie HH, Brittain HM, Norton JA, Rodgers DD, et al. (1993) The development of a dementia screening interview in two distinct languages. Int J Meth Psych Res 3: 1-28.
103. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M (2003) Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 361: 909-917.
104. Reynolds T, Thornicroft G, Abas M, Woods B, Hoe J, et al. (2000) Camberwell Assessment of Need for the Elderly (CANE). Development, validity and reliability. Br J Psychiatry 176: 444-452.
105. Thorgrimsen L, Spector A, Wiles A, Orrell M (2003) Aroma therapy for dementia. Cochrane Database Syst Rev: CD003150.
106. Institute of Development and Policy Management/HelpAge International (2003) Non-contributory pensions and poverty prevention. A comparative study of Brazil and South Africa. Final Report, DFID Project R7897, Pensions and Poverty Prevention. Manchester (United Kingdom): Institute of Development and Policy Management and London: HelpAge International. Available: http://www.helpage.org/ Resources/Researchreports/Non-contributorypensions. Accessed 5 October 2009.
107. UK Department of Health (2009) Living well with dementia. A National Dementia Strategy. Available: http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH-094058. Accessed 5 October 2009.